Sterol Derivatives for Cochlear Implant Neuron Survival
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for hearing loss, particularly sensorineural hearing loss, are inadequate as they either fail to prevent degeneration of spiral ganglion neurons or come with significant side effects, and there is a need for a solution that can restore or maintain auditory function without increasing neuron numbers.
Innovation Solution
A pharmaceutical composition containing specific sterol derivatives, such as those of formula I, is administered to the cochlea to promote axonal regrowth and improve connections between spiral ganglion neurons and hair cells or cochlear implant electrodes, enhancing the effectiveness of cochlear implants and restoring auditory function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If neurotrophic factors are used to promote axonal regrowth and neuronal survival, then hearing function is improved, but side effects such as weight loss, uncontrolled cell migration, and cancer risk occur
Solution Approach 1:
The patent uses sterol derivatives as intermediary compounds that indirectly promote axonal regrowth and neuronal survival through modulating cell membrane fluidity and signaling pathways, rather than directly administering neurotrophic factors. This mediator approach achieves the desired therapeutic effect while avoiding the harmful side effects of direct neurotrophic factor administration.
Solution Approach 2:
The patent changes the chemical parameter from neurotrophic factors to sterol derivatives with specific molecular structures (formula I). This parameter change maintains the beneficial effect on axonal regrowth while eliminating the problematic side effects, as sterols act through different mechanisms involving membrane fluidity modulation and secondary signaling pathways.
2Reliability
If cochlear implants are used to replace hair cells, then hearing transmission is restored, but spiral ganglion neuron degeneration continues unchecked
Solution Approach 1:
The patent applies sterol derivatives as a preliminary protective treatment before or during cochlear implantation to prevent spiral ganglion neuron degeneration. By treating the neurons in advance with compounds that stabilize cell membranes and promote survival, the patent ensures long-term neuron integrity and sustained hearing function throughout the implant's operational life.
Solution Approach 2:
The patent establishes continuous protection against neuron degeneration through sustained administration of sterol derivatives. This continuous therapeutic action maintains neuron health over time, ensuring that the cochlear implant remains effective throughout its service life by preventing the gradual neuron loss that would otherwise occur.
3Reliability
If axonal regrowth is promoted to improve cochlear implant effectiveness, then connection quality improves, but the mechanism is not fully understood and may lead to uncontrolled cell migration
Solution Approach 1:
The patent employs sterol derivatives that leverage the body's natural cellular mechanisms to promote controlled axonal regrowth. By modulating membrane fluidity and activating endogenous signaling pathways, the compounds enable the neurons to self-regulate their regrowth process without requiring complex external control systems, achieving connection improvement through biologically natural processes.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The invention relates to a composition for preventing hearing loss in a subject or for at least partially restoring hearing in a subject having a reduced auditory function. The composition comprises at least one sterol compound inducing neuron differentiation. Said composition is placed in contact with at least part of the cochlea.